ARKK vs INMB
ARK Innovation ETF (ARKK) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
ARKK currently screens at market cap $0. INMB currently screens at market cap $33.5M.
Not investment advice. Open the ARKK and INMB stock pages for the full models.
Not investment advice.